1
/
of
0
FDA Drug Approval, N012429, THIOGUANINE
FDA Drug Approval, N012429, THIOGUANINE
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 012429
Company: WAYLIS THERAP
Drug Name: THIOGUANINE
Active Ingredients: THIOGUANINE
Strength: 40MG
Dosage Form/Route: TABLET;ORAL
Action Date: 01/18/1966
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Company: WAYLIS THERAP
Drug Name: THIOGUANINE
Active Ingredients: THIOGUANINE
Strength: 40MG
Dosage Form/Route: TABLET;ORAL
Action Date: 01/18/1966
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details